Are These 5 Popular Stocks Buys Or Sells?

Posted on by The INO.com Team

Yesterday the indices came crashing down, breaking through key levels and turning all of the major indicators into strong downtrends. There is no question in my mind that we are now in a full-blown bear market. So how much further down can the market go from here?

In today's video, I will be looking at some downside target areas for all three major indices, as well as five popular stocks.

I will also be looking at these stocks to determine whether or not they present a buying opportunity based on the recent weakness in the market. Continue reading "Are These 5 Popular Stocks Buys Or Sells?" →

Stock Whisper Of The Day

Posted on by The INO.com Team

The Stock Whisperer, Stefanie Kammerman, shows you how she uses pre-market price action to pick the hottest stocks of the day.

Stefanie Kammerman has taught thousands of traders worldwide how to day trade and swing trade over the past 21 years. She is the founder and director of The Stock Whisperer Trading Company, where she runs an online trading room called The Java Pit.

She offers numerous workshops, live classes and bootcamps on everything from discipline and the psychological aspects of trading, to how to identify the best levels to trade and how to spot when the big money is buying. Learn by watching her trade as she teaches her students how to read the tape and trade around the dark pool.

Enjoy,
The INO.com Team

McKesson Corporation Presents A Compelling Investment Opportunity

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

McKesson Corporation (MCK) presents a compelling investment opportunity in the healthcare space, particularly after the recent sell-off from $243 to below $200 per share. In brief, McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technology. The Company operates in two segments. The McKesson Distribution Solutions segment distributes drugs, equipment and health and beauty care products domestically and internationally. This segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes clinical solutions, claims payment solutions and network performance tools. This segment delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services.

McKesson is driving growth via acquisitions and partnerships

MCK recently acquired the pharmaceutical distribution division of UDG Healthcare plc for €408 million in cash. This acquisition will add a leader in pharmaceutical distribution across the Republic of Ireland and Northern Ireland to McKesson's European business. Marc Owen, Chairman of the Management Board at Celesio AG, said: "The acquisition of UDG's pharmaceutical distribution, home and travel healthcare businesses in Ireland and the UK, will strengthen our position in the industry. We have made this investment as part of our growth strategy which leverages the positive trajectory of the wider healthcare sector in Europe. This acquisition will also complement our broader portfolio of assets in both Ireland and the United Kingdom. We look forward to continuing UDG's tradition of excellent customer service and to working with the UDG team." Continue reading "McKesson Corporation Presents A Compelling Investment Opportunity" →

Death By 1000 Rate Hikes

Posted on by The INO.com Team

As we rapidly approach the end of the third quarter it would appear as though the Fed's strategy is to let out these "trial balloons," saying that interest rates will be raised later this year.

The latest Fed spokesman to float another trial balloon was the New York Federal Reserve president, William Dudley. Mr. Dudley is a voting member of the Fed's policy setting committee. Mr. Dudley stated that the Fed will likely raise rates later this year. How many times do they have to tell us that?

I have said this before and I believe the Fed has no idea how to get out of this pickle that it has got the country in. This addiction to low cost money is not healthy and I was happy to see this morning that Carl Icahn has the same mindset. Mr. Icahn thought the Fed should have raised interest rates six months ago, I would've said at least 12 months ago, but all that is a moot point right now.

With only three trading days left till end of the third quarter, all the major markets I track are lower for the month and the quarter. I view this as a significant market clue indicating that the markets have not yet finished on the downside.

Here is were the markets closed last month. All of these major indices are lower for both the month and the quarter. Continue reading "Death By 1000 Rate Hikes" →

"Interest Rates Drive Stocks"? See 4 Charts That Tell You the Truth

Posted on by The INO.com Team

By: Elliott Wave International

Robert Prechter's monthly Elliott Wave Theorist once published a ten-part study explaining why traditional financial models failed to foresee the 2007-2009 financial crisis -- and, more importantly, why they are doomed to fail again (and again).

On Thursday (Sept. 17), the Fed decided to keep interest rates unchanged. On Friday, stocks opened down big. But before you join those who blame it on the Fed, please read this excerpt from Prechter's eye-opening study.

***************

Economic theory holds that bonds compete with stocks for investment funds. The higher the income that investors can get from safe bonds, the less attractive is a set rate of dividend payout from stocks; conversely, the less income that investors can get from safe bonds, the more attractive is a set rate of dividend payout from stocks. A statement of this construction appears to be sensible.

And it would be, if it were made in the field of economics. For example, "Rising prices for beef make chicken a more attractive purchase." This statement is simple and true. But in the field of finance such statements fly directly in the face of the evidence.

Figure 3 shows a history of the four biggest stock market declines of the past hundred years. They display routs of 54% to 89%. Continue reading ""Interest Rates Drive Stocks"? See 4 Charts That Tell You the Truth" →